Table 2 Baseline demographic and clinical variables of the Traumeel S® and placebo treatment groups.
From: Traumeel S® for pain relief following hallux valgus surgery: a randomized controlled trial
Traumeel S® (n = 39) | Placebo (n = 40) | |
|---|---|---|
Clinical Center: | ||
SZMC* | 33 | 34 |
MMC** | 6 | 6 |
Age (y) | ||
Mean (SD) | 48.1 (16.7) | 45.2 (18.7) |
< 50 | 17 | 19 |
≥ 50 | 22 | 21 |
Sex (%) | ||
M | 8 (20.5) | 8 (20.0) |
F | 31 (79.5) | 32 (80.0) |
Ethnicity/Origin (%) | ||
Europe/America | 12 (30.8) | 9 (22.5) |
Asia/Africa | 21 (53.9) | 25 (62.5) |
Israeli Arab | 2 (5.1) | 0 |
Mixed | 2 (5.1) | 2 (5.0) |
Other | 2 (5.1) | 4 (10.0) |
BMI | ||
Mean (SD) | 24.7 (4.1)† | 24.3 (4.0)† |
< 24 | 20 | 23 |
≥ 24 | 18 | 16 |
Pain before surgery | ||
Mean (SD) | 5.4 (2.8) | 5.7 (2.6)† |
< 6 | 19 | 18 |
≥ 6 | 20 | 21 |
Laterality (%) | ||
Right | 21 (53.9) | 14 (35.9)† |
Left | 16 (41.0) | 24 (61.5) |
Bilateral# | 2 (5.1) | 1 (2.6) |
Type of surgery (%) | ||
Chevron - only | 9† (23.0) | 10†† (26.3) |
Additional | 17 (43.5) | 18 (47.3) |
osteotomy | ||
Triple or | 13 (33.3) | 10 (26.3) |
proximal | ||
osteotomy |